... OncologyOpen AccessCase reportThe use of fulvestrant, a parenteral endocrine agent, in intestinal obstruction due to metastatic lobular breast carcinomaJasmine YM Tang*, Rajendra Singh Rampaul and ... M, Asselain B, Vincent-Salomom A, BeuzebocP: Infiltrating lobular carcinoma of the breast: clinico-patholgic analysis of 975 cases with reference to data on con-servative therapy and metastatic ... hormonal or cytotoxictherapy for advanced breast cancer [12].Conclusion Fulvestrant, is the only available parenteral endocrine agent for postmenopausal advanced breast cancer, andhas the...